Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C1orf116 |
| Upstream (Parents) |
|---|
| (<<) RAB25 → C1orf116 |
| (<<) CDCP1 → C1orf116 |
| Downstream (Children) |
|---|
| C1orf116 → MTMR11 (>>) |
| C1orf116 → TEX13B (>>) |
| C1orf116 → C11orf80 (>>) |
| C1orf116 → BCL2L1 (>>) |
| C1orf116 → SH3YL1 (>>) |
| C1orf116 → VILL (>>) |
| C1orf116 → ASAP2 (>>) |
| C1orf116 → RCAN3 (>>) |
| C1orf116 → UNC93B1 (>>) |
| C1orf116 → ITGB6 (>>) |
| C1orf116 → SH3GLB2 (>>) |
| C1orf116 → EVX1 (>>) |
| C1orf116 → PRRG2 (>>) |
| C1orf116 → OVOL1 (>>) |
| C1orf116 → TRIM16 (>>) |
| C1orf116 → C7orf16 (>>) |
| C1orf116 → PSORS1C1 (>>) |
| C1orf116 → SYTL2 (>>) |
| C1orf116 → NBEAL2 (>>) |
